The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 10, 2015

Filed:

Jan. 22, 2009
Applicants:

John Matsoukas, Patras, GR;

Theodoros Tselios, Mesologgi, GR;

Vasso Apostolopoulos, St. Albans, AU;

Vivian Tseveleki, Drosia, GR;

Maria Katsara, Kalamata, GR;

Lesley Probert, Athens, GR;

Inventors:

John Matsoukas, Patras, GR;

Theodoros Tselios, Mesologgi, GR;

Vasso Apostolopoulos, St. Albans, AU;

Vivian Tseveleki, Drosia, GR;

Maria Katsara, Kalamata, GR;

Lesley Probert, Athens, GR;

Assignee:

VIANEX S.A., Attikis, GR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 14/47 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0008 (2013.01); C07K 14/4713 (2013.01); A01K 2207/10 (2013.01); A01K 2227/105 (2013.01); A01K 2267/0325 (2013.01); A61K 2039/6087 (2013.01); A61K 2039/627 (2013.01);
Abstract

A first aspect of the invention relates to a conjugate including mannan and at least one epitope comprising a peptide fragment of a protein selected from myelin basic protein (MBP), myelin oligodentrocyte glycoprotein (MOG) and proteolipid protein (PLP), said peptide fragment being in linear or cyclic form; and wherein said epitope is linked to mannan via a [(Lys-Gly)] bridge, where n is an integer from 1 to 10. Further aspects of the invention relate to pharmaceutical compositions comprising said conjugates, and their use in the preparation of a medicament for treating an immune disorder.


Find Patent Forward Citations

Loading…